PLENARY LECTURE

Melanie Anderson, PhD

Principal Scientist @ Merck

Merck's Strategy Around Decentralized Trials, Bioanalytical Sampling & Logistics

Karan Agrawal, PhD

Scientist, Bioanalytical Discovery & Development @ Janssen Research & Development

Evaluating a Hybrid LC-MS/MS Approach for the Quantification of siRNA Analytes

Suresh Paddigari, PhD

Team Lead @ Moderna

RT-qPCR Method Development and Validation for mRNA Analysis

Liang Zhu, PhD

Director, Clinical Biomarker Laboratories @ Moderna

Vaccine Bioanalysis Focused on Immunogenicity

Arkadeep Sinha, PhD

Bioanalytical Scientist @ EMD Serono

Chasing the Matrix Interference in a Bispecific ADA Assay - Divergent Target Interference Based on a Patient Geography

Heather Cohen, PhD

Senior Director, Translational Sciences @ Bicycle Therapeutics

Peptide conjugates - Title TBA

Steven Louie, PhD

Senior Principal Scientist @ Novartis Institutes for BioMedical Research

Preclinical aspects of PROTACS - TBA

Upendra Dahal, PhD

Senior Principal Scientist @ Amgen

KRAS inhibitor - Title TBA

Anette Karle, PhD

Senior Principal Scientist Immunogenicity @ Novartis (Switzerland)

MAPPS - title TBA

Edward Price, PhD

Senior Scientist II, DMPK-BA @ AbbVie

Mechanistic absorption models in the bRo5 chemical space - Title TBA

Joleen White, PhD

Head of Bioassay Development & Operations @ Bill and Melinda Gates Medical Research Institute

Patient Centric Sampling in the Therapeutic Development Programs

Joe Cannon, PhD

Scientific Associate Director @ Bristol Myers Squibb

Investigating Permeability of Heterobifunctional Protein Degraders

Yuting Wang, PhD

Senior Scientist (DMPK-BA) @ AbbVie

Bioanalytical Strategies for Characterization and PK Assessment of Multi-specific Antibodies

Lei Ci, PhD

Associated Scientific Director @ Moderna

Oligonucleotide-based therapeutics - Title TBA

Saravanan Ayyadurai, PhD

Senior Scientist, Global DMPK @ Takeda

NanoString-based High Throughput MicroRNA Biomarker Assay Development